PETRA LAMLA-LABAN: Open Payments
NPI 1104539428 · ALBUQUERQUE, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$860 in 23 payments from 9 companies in 2025. Trend: 2023 $807 · 2024 $1,376 · 2025 $860
Food & beverage: $860
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $308 |
| Alpha Cognition USA, Inc. | 1 | $145 |
| Alkermes, Inc. | 1 | $122 |
| Neurocrine BioSciences, Inc. | 1 | $119 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $82 |
| E.R. Squibb & Sons, L.L.C. | 2 | $30 |
| Teva Pharmaceuticals USA, Inc. | 1 | $21 |
| Axsome Therapeutics, Inc. | 1 | $19 |
| Janssen Pharmaceuticals, Inc | 1 | $15 |
Products named: VRAYLAR, Zunveyl, LYBALVI, INGREZZA, CAPLYTA, COBENFY, UZEDY, Sunosi.
Industry payments across NM — which companies pay providers there.
